Peripheral endocannabinoid microdialysis: in vitro characterization and proof-of-concept in human subjects

被引:0
|
作者
Alexander A. Zoerner
Christin Rakers
Stefan Engeli
Sandor Batkai
Marcus May
Jens Jordan
Dimitrios Tsikas
机构
[1] Hannover Medical School,Institute for Clinical Pharmacology
来源
Analytical and Bioanalytical Chemistry | 2012年 / 402卷
关键词
Microdialysis; Endocannabinoids; Anandamide; 2-Arachidonoyl glycerol; LC-MS/MS; Hydroxypropyl-ß-cyclodextrine;
D O I
暂无
中图分类号
学科分类号
摘要
In vivo endocannabinoid (EC) microdialysis has only seldom been performed, mostly in rodent brain tissue. Low solubility in aqueous media, adsorption to surfaces, and instability with co-present human serum albumin (HSA) are the major obstacles in EC microdialysis. The addition of hydroxypropyl-ß-cyclodextrine (HPCD) to the perfusion fluid has been previously described to facilitate lipid microdialysis, but the general biophysical properties of HPCD, especially with respect to peripheral EC microdialysis, have not been described before. We report on the characterization of EC microdialysis using an in vitro system using Ringer’s solution with 10% HPCD as the perfusion fluid and with fatty acid-free HSA as the matrix fluid. The endocannabinoids anandamide (AEA) and 2-arachidonoyl glycerol (2AG) were measured using LC-MS/MS. AEA was stable in the perfusion and matrix fluids, whereas 2AG was only stable in the perfusion fluid. In the matrix fluid, 2AG underwent rapid isomerization to 1-arachidonoyl glycerol. A relative recovery of 3.5% for AEA was found with 10% HPCD in the perfusion fluid and a flow rate of 1 μL/min. For 2AG, a similar relative recovery of 3.5% was estimated. Since 2AG was found unstable in the matrix fluid, a reliable calculation of the relative recovery rates was not possible. Delivery and recovery experiments revealed unequal inward and outward EC transport across the microdialysis membrane. Contrary to usual microdialysis findings, we observed increasing recovery rates for AEA with increasing flow rates. Long equilibration times of several hours were necessary to obtain constant relative recovery rates. In a proof-of-concept study in humans, we collected AEA from subcutaneous abdominal adipose tissue employing the described methodology. Our study suggests that the microdialysis technique is not suitable for the exact quantification of tissue EC concentrations, but it allows for their rough estimation.
引用
收藏
页码:2727 / 2735
页数:8
相关论文
共 50 条
  • [41] State-Dependent Biomechanical Behavior of Oropharyngeal Structures in Apneic and Control Subjects A Proof-of-Concept Study
    Schwab, Richard J.
    Lin, Theodore C.
    Wiemken, Andrew
    Dedhia, Raj C.
    Wehrli, Felix W.
    Keenan, Brendan T.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (06) : 949 - 960
  • [42] Anti-infective potential of natural products: How to develop a stronger in vitro 'proof-of-concept'
    Cos, Paul
    Vlietinck, Arnold J.
    Vanden Berghe, Dirk
    Maes, Louis
    JOURNAL OF ETHNOPHARMACOLOGY, 2006, 106 (03) : 290 - 302
  • [43] Growth hormone secretagogues in Duchenne muscular dystrophy: preclinical proof-of-concept in vivo and in vitro assays
    Mantuano, P.
    Boccanegra, B.
    Bresciani, E.
    Sanarica, F.
    Mele, A.
    De Bellis, M.
    Cappellari, O.
    Liantonio, A.
    Denoyelle, S.
    Torsello, A.
    De Luca, A.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S77 - S77
  • [44] Development and In Vitro Proof-of-Concept of Interstitially Targeted Zinc-Phthalocyanine Liposomes for Photodynamic Therapy
    Broekgaarden, M.
    de Kroon, A. I. P. M.
    van Gulik, T. M.
    Heger, M.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (03) : 377 - 391
  • [45] Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study
    Sahoo, Dipak Kumar
    Martinez, Marilyn N.
    Dao, Kimberly
    Gabriel, Vojtech
    Zdyrski, Christopher
    Jergens, Albert E.
    Atherly, Todd
    Iennarella-Servantez, Chelsea A.
    Burns, Laura E.
    Schrunk, Dwayne
    Volpe, Donna A.
    Allenspach, Karin
    Mochel, Jonathan P.
    CELLS, 2023, 12 (09)
  • [46] Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept
    Papadia, Konstantina
    Markoutsa, Eleni
    Mourtas, Spyridon
    Giannou, Anastassios D.
    La Ferla, Barabara
    Nicotra, Fransesco
    Salmona, Mario
    Klepetsanis, Pavlos
    Stathopoulos, Georgios T.
    Antimisiaris, Sophia G.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 101 : 140 - 148
  • [47] Development and in vitro proof-of-concept of interstitially targeted zinc-phthalocyanine liposomes for photodynamic therapy
    Broekgaarden, Mans
    de Kroon, Anton I. P. M.
    van Gulik, Thomas M.
    Heger, Michal
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 65 : S16 - S16
  • [48] Raman spectroscopy for the preoperative diagnosis of thyroid cancer and its subtypes: An in vitro proof-of-concept study
    O'Dea, Declan
    Bongiovanni, Massimo
    Sykiotis, Gerasimos P.
    Ziros, Panos G.
    Meade, Aidan D.
    Lyng, Fiona M.
    Malkin, Alison
    CYTOPATHOLOGY, 2019, 30 (01) : 51 - 60
  • [49] INFLUENCE OF DIETARY FAT ON THE PERIPHERAL ENDOCANNABINOID-SYSTEM IN LEAN AND OBESE HUMAN SUBJECTS
    Engeli, S.
    Lehmann, A. -C.
    Boehnke, J.
    Haas, V.
    Janke, J.
    Strauss, A.
    Zoerner, A.
    Tsikas, D.
    Jordan, J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 53 - 53
  • [50] Optimising testing strategies for classification of human health and environmental hazards - A proof-of-concept study
    Da Silva, Emilie
    Baun, Anders
    Berggren, Elisabet
    Worth, Andrew
    TOXICOLOGY LETTERS, 2020, 335 : 64 - 70